We confirmed both the BRD2‐FTH1 interaction and the nuclear co‐localization of the BRD2‐FTH1 complex through immunofluorescence analysis in all three NSCLC cell lines (Fig. 3A–C). The gene discussed is FTH1; the disease is non-small cell lung carcinoma.